Search Results - Heming Li

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    A real-world study on the efficacy and safety of low-dose PD-1 monoclonal antibody alone or in combination as the first-line treatment for advanced non-small cell lung cancer

    A real-world study on the efficacy and safety of low-dose PD-1 monoclonal antibody alone or in combination as the first-line treatment for advanced non-small cell lung cancer by Tao Han, Xin Li, Lu Xu, Jingqi Sun, Junli Hao, Sha Shi, Heming Li, Mingfang Zhao

    Published 2025-06-01

    Background In clinical practice, patients with non-small cell lung cancer (NSCLC) often receive low-dose programmed death-1 (PD-1) monoclonal antibodies due to physical or financial limitations. However, the efficacy and safety of low-dose compared with standard-dose PD-1 monoclonal antibodies remai...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: